Janus Living, Inc.

JAN

Market cap $6.02B

Janus Living debuted as the only U.S. REIT focused exclusively on senior housing, operating under a unique RIDEA structure. JAN's portfolio spans 34 communities, heavily concentrated in Texas and Florida, with 85% occupancy and $771 million in 2025 revenues. At a $24 share price, Janus trades at a demanding 25x adjusted FFO, with a reduced 2.4% dividend yield post-IPO.

REITs were rolling out of the gates in early-2026, coming back into favor amid a HALO trade (Heavy Assets, Low Obsolescence) after a half-decade of rate headwinds and unfavorable narrative. The oil price surge tied to the Iran conflict has complicated the rotation by sending rates soaring, yet REITs have remained surprisingly resilient in recent weeks, maintaining sizable year-to-date outperformance. REIT-rate correlations have eased in recent quarters, signaling a more favorable "regime change" where performance is driven by property fundamentals rather than macro forces, following a prolonged period of rate-dominated.

DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced today that it has closed on a new $500 million unsecured revolving credit facility (the “Revolving Facility”) and a $100 million unsecured delayed-draw term loan facility (the “Term Loan”, and together with the Revolving Facility, the “Credit Facility”). The Revolving Facility provides for borrowing up to $500 million and matures in March 2030, with.

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (NYSE: JAN) (“Janus Living”) announced today that Janus Living has completed its initial public offering of 48,300,000 shares of its Class A-1 common stock, which includes the exercise in full by the underwriters of their option to purchase up to an additional 6,300,000 shares of Class A-1 common stock, at a price to the public of $20.00 per share. Shares of Janus Living's Class A-1 common sto.

Three IPOs priced this past week, joined by two SPACs, and one major issuer joined the pipeline. One IPO and one direct listing are currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week. Street research is expected for one company in the week ahead, and three lock-up periods will be expiring.